ArticleCureus2024
Fasting Glycemia, Glycosylated Hemoglobin and Malnutrition Inflammation Are Associated With Sarcopenia in Older People With Chronic Kidney Disease Undergoing Hemodialysis Treatment: A Cross-Sectional Study.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Unravelling Sarcopenia in Chronic Kidney Disease: From Pathogenesis to Diagnosis and Therapeutics.Diagnostics (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundContradictory data are available on the possible association between sarcopenia and other clinical disorders in patients with chronic kidney disease (CKD) undergoing hemodialysis.
objectiveTo determine the association between sarcopenia and markers associated with systemic inflammation, fasting glycemia, and quality of life in older people with CKD undergoing hemodialysis.
methodsThis was an analytical cross-sectional study. People over 60 years with stage 5 CKD undergoing hemodialysis were invited to participate. Sarcopenia was assessed using the criteria of the European Working Group on Sarcopenia in Older People. Clinical variables such as body mass index, comorbidities, malnutrition inflammation, quality of life, fasting glycemia, glycosylated hemoglobin, hematocrit, uremia, creatinine, sodium, calcium, potassium, albumin, ferritin, C reactive protein were measured.
resultsTwenty-three patients with CKD were included. The prevalence of sarcopenia was 56.5%. Sarcopenic participants showed higher fasting glycemia, glycosylated hemoglobin, and malnutrition inflammation, as well as expected lower physical performance compared to nonsarcopenic participants. Correlations that ranged from moderate to strong were observed between sarcopenia and clinical characteristics such as fasting glycemia (r=0.48; P<0.05), glycosylated hemoglobin (r=0.44; P<0.05), malnutrition inflammation (r=0.46; P<0.05), skeletal muscle mass (r=-0.70;
conclusionsIn a sample of older people with CKD who underwent hemodialysis, sarcopenia was correlated with fasting glycemia, glycosylated hemoglobin, and malnutrition inflammation. However, only fasting glycemia was found to be a significant predictor of sarcopenia. More studies are needed to determine the influence of glycemic control on sarcopenia in older people with CKD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.